Table 1.
No . |
Name | RT (min ) |
Formul a |
MW (Da) |
Measu red (Da)a |
Err or (pp m) |
Main MS/MS fragment ions |
Ref . |
---|---|---|---|---|---|---|---|---|
1 | Majonoside R1/isomer |
3.21 1 |
C42H72 O15 |
816.48 72 |
815.48 15 |
2.5 | 653.4313 [M−H−Glc]−; 635.4169 [M−H−Glc−H2O]−; 491.3742 [M−H−2Glc]− |
27 |
2 | Notoginsenoside N1/isomer |
3.64 3 |
C48H82 O19 |
962.54 5 |
961.54 05 |
3.4 | 799.4956 [M−H−Glc]−;781.4812 [M−H−Glc−H2O]− |
27 |
3 | Majonoside R1/isomer |
6.31 1 |
C42H72 O15 |
816.48 72 |
815.48 00 |
0.7 | 653.4299 [M−H−Glc]−; 635.4299 [M−H−Glc−H2O]−; 491.3761 [M−H−2Glc]− |
27 |
4 | 20-glc-Rf | 7.43 2 |
C48H82 O19 |
962.54 50 |
961.53 85 |
1.4 | 799.4893 [M−H−Glc]−; 637.4316 [M−H−2Glc]−; 475.3767 [M−H−3Glc]− |
23, 25 |
5 | Notoginsenoside R1 |
7.85 1 |
C47H80 O18 |
932.53 45 |
931.52 75 |
0.8 | 799.4871 [M−H−Glc]−; 637.4315 [M−H−Araf−Glc]−; 475.3794 [M−H−Araf−2Glc]− |
23, 28 |
6 | Ginsenoside Rg1 | 8.58 5 |
C42H72 O14 |
800.49 22 |
799.48 68 |
2.4 | 637.4321 [M−H−Glc]−; 475.3798 [M−H−2Glc]− |
23, 28 |
7 | Ginsenoside Re | 8.64 5 |
C48H82 O18 |
946.55 01 |
945.54 58 |
3.2 | 799.4918 [M−H−Rha]−; 783.4956 [M−H−Glc]−; 637.4348 [M−H−Rha−Glc]−; 475.3806 [M−H−Rha−Glc]− |
23, 28 |
8 | Notoginsenoside A/isomer |
9.92 3 |
C54H92 O24 |
1124.5 979 |
1123.5 901 |
0 | 961.5431 [M−H−Glc]−; 799.4781 [M−H−2Glc]−; 781.4802 [M−H−2Glc−H2O]− |
27 |
9 | Ginsenoside Rf | 13.2 36 |
C42H72 O14 |
800.49 22 |
799.48 19 |
−3.1 | 637.432 [M−H−Glc]−; 475.3768 [M−H−2Glc]− |
23, 28 |
10 | Bu-Rg1 | 13.3 57 |
C46H76 O15 |
868.51 84 |
867.51 34 |
3.2 | 799.4899 [M−H−Bu]−; 637.4337 [M−H−Bu−Glc]−; 475.3741 [M−H−Bu−2Glc]− |
22 |
11 | Ginsenoside Ra3 | 13.8 98 |
C59H100 O27 |
1240.6 452 |
1239.6 330 |
−3.5 | 1107.6207 [M−H−Xyl]−; 945.5357 [M−H−Xyl−Glc]−; 783.5173 [M−H−Xyl−2Glc]−; 621.4370 [M−H−Xyl−3Glc]−; 459.3882 [M−H−Xyl−4Glc]− |
28 |
12 | Notoginsenoside Fa |
13.9 64 |
C59H100 O27 |
1240.6 452 |
1239.6 319 |
−4.4 | 1107.5786 [M−H−Xyl]−; 945.5450 [M−H−Xyl−Glc]−; 783.4880 [M−H−Xyl−2Glc]−; 621.4380 [M−H−Xyl−3Glc]−; 459.3845 [M−H−Xyl−4Glc]− |
24 |
13 | Notoginsenoside R2 |
14.5 32 |
C41H70 O13 |
770.48 16 |
769.47 20 |
− 2.3 |
637.4273 [M−H−Xyl]−; 475.3757 [M−H−Xyl−Glc]− |
23, 28 |
14 | Ginsenoside Rg2 | 16.3 16 |
C42H72 O13 |
784.49 73 |
783.48 70 |
−3.2 | 637.4311 [M−H−Rha]−; 475.3781 [M−H−Rha−Glc]− |
23, 28 |
15 | Ginsenoside Rh1 | 16.5 47 |
C36H62 O9 |
638.43 94 |
637.43 30 |
1.4 | 475.3765 [M−H−Glc]− |
23, 28 |
16 | Bu-Re | 16.8 54 |
C52H86 O19 |
1014.5 763 |
1013.5 708 |
2.3 | 945.5451 [M−H−Bu]−; 799.4853 [M−H-Bu−Rha]−; 637.4331 [M−H-Bu−Rha−Glc]−; 475.3772 [M−H-Bu−Rha−2Glc]− |
22 |
17 | Ginsenoside Ra1 | 17.3 41 |
C58H98 O26 |
1210.6 346 |
1209.6 272 |
0.3 | 1077.6158 [M−H−Xyl]−; 945.5423 [M−H−Xyl−Arap]−; 783.4917 [M−H−Xyl−Arap−Glc]−; 765.4602 [M−H−Xyl−Arap−Glc−H2O] −; 621.4410 [M−H−Xyl−Arap−2Glc]−; 459.3818 [M−H−Xyl−Arap−3Glc]− |
28 |
18 | Bu-Rf | 17.6 88 |
C46H76 O15 |
868.51 84 |
867.51 13 |
0.8 | 799.5486[M−H−Bu]−; 637.4282 [M−H−Bu−Glc]−; 475.3801 [M−H−Bu−2Glc]− |
22 |
19 | Ginsenoside Rb1 | 18.1 90 |
C54H92 O23 |
1108.6 029 |
1107.5 911 |
−3.6 | 945.5507 [M−H−Glc]−; 783.4896 [M−H−2Glc]−; 621.4381 [M−H−3Glc]−; 459.3838 [M−H−4Glc]− |
23, 28 |
20 | Malonyl-Rb1 | 20.3 06 |
C57H94 O26 |
1194.6 033 |
1193.5 993 |
2.8 | 1107.6072 [M−H−mal]−; 945.5593 [M−H−mal−Glc]−; 783.4674 [M−H−mal−2Glc]−; 765.4901 [M−H−mal-2Glc−H2O]−; 621.4435 [M−H−mal−3Glc]− |
23, 28 |
21 | Ginsenoside Rc | 20.7 34 |
C53H90 O22 |
1078.5 924 |
1077.5 846 |
0 | 945.0000 [M−H−Araf]−; 783.0000 [M−H−Araf−Glc]−; 621.0000 [M−H−Araf−2Glc]−; 459.3812 [M−H−Araf−3Glc]− |
23, 28 |
22 | Ginsenoside Ro | 20.9 29 |
C48H76 O19 |
956.49 81 |
955.47 36 |
−1.7 | 955.4828 [M−H]−; 793.4456 [M−H−Glc]−; 713.427[M−H−Glc−CO2−H2 O]−; 613.3784 [M−H-2Glc−H2O]−; 569.3766 [M−H−2Glc−CO2−H2O]−; 455.3549 [M−H-3Glc−Acid]− |
23, 28 |
23 | Ginsenoside Ra2 | 21.7 08 |
C58H98 O26 |
1210.6 346 |
1209.6 202 |
1.7 | 1077.6158 [M−H−Xyl]−; 945.5381 [M−H−Xyl−Araf]−; 783.4853 [M−H−Xyl−Araf−Glc]−; 765.4739 [M−H−Xyl−Araf−Glc−H2O] −; 621.4294 [M−H−Xyl−Araf−Glc−H2O] −; 459.3787 [M−H−Xyl−Araf−3Glc]− |
28 |
24 | Ginsenoside F1 | 23.5 59 |
C36H62 O9 |
638.43 94 |
637.43 39 |
3.6 | 475.3816 [M−H−Glc]− | 28 |
25 | Malonyl-Rc | 23.8 07 |
C56H92 O25 |
1164.5 928 |
1163.5 887 |
2.7 | 1119.5898 [M−H−CO2]−; 1077.577 [M−H−mal]−; 945.5308 [M−H−mal-Araf]−; 783.4829 [M−H−mal-Araf−Glc]−; 621.4227 [M−H−mal-Araf−2Glc]−; 459.3813 [M−H−mal-Araf−3Glc]− |
23, 28 |
26 | Malonyl-Rb2 | 23.9 27 |
C56H92 O25 |
1164.5 928 |
1163.5 867 |
1.0 | 1119.5893 [M−H−CO2]−; 1077.5760 [M−H−mal-Arap]−; 945.5363 [M−H−mal-Arap]−; 783.4904 [M−H−mal-Arap−Glc]−; 621.4354 [M−H−mal-Arap−2Glc]− |
23, 28 |
27 | Malonyl-Ra1/ Malonyl-Ra2 |
24.5 01 |
C61H100 O29 |
1296.6 350 |
1295.6 299 |
1.7 | 1209.6272 [M−H−mal]−; 1077.6158 [M−H−mal−Xyl]−; 945.5423 [M−H−mal−Xyl−Ara]−; 783.4917[M−H−mal−Xyl−A ra−Glc]−; 765.4602 [M−H−mal]−Xyl−Ara−Glc− H2O]−; 621.4410[M−H−mal]−Xyl− Ara−2Glc]−; 459.3818[M−H−mal−Xyl−A ra−3Glc]− |
28 |
28 | Ginsenoside Rb2 | 25.0 78 |
C53H90 O22 |
1078.5 824 |
1077.5 761 |
0.9 | 945.5345 [M−H−Arap]−; 783.4844 [M−H−Arap−Glc]−; 621.4313 [M−H−Arap−2Glc]−; 459.3813 [M−H−Arap−3Glc]− |
23, 28 |
29 | Ginsenoside Rb3 | 26.7 16 |
C53H90 O22 |
1078.5 924 |
1077.5 846 |
0 | 945.0000 [M−H−Xyl]−; 783.0000 [M−H−Xyl−Glc]−; 621.4186 [M−H−Xyl−2Glc]−; 459.3711 [M−H−Xyl−3Glc]− |
23, 28 |
30 | Malonyl-Rb3 | 27.8 90 |
C56H92 O25 |
1164.5 928 |
1163.5 896 |
3.5 | 1119.5832 [M−H−CO2]−; 1077.5738 [M−H−mal]−; 945.5557 [M−H−mal−Xyl]−; 783.4785 [M−H−mal−Xyl−Glc]−; 621.4281 [M−H−mal−Xyl−2Glc]− |
23, 28 |
31 | Notoginsenoside Fc |
28.2 78 |
C58H98 O26 |
1210.6 346 |
1209.6 222 |
−3.8 | 1077.6158 [M−H−Xyl]−; 945.5410 [M−H−Xyl−Arap]−; 783.4793 [M−H−Xyl−Arap−Glc]−; 621.4312 [M−H−Xyl−Arap−2Glc]−; 459.3830 [M−H−Xyl−Arap−3Glc]− |
24 |
32 | Quinquenoside R1 | 28.7 63 |
C56H94 O24 |
1150.6 135 |
1149.6 118 |
−2.8 | 1107.5836 [M−H−AC]−; 1089.5745 [M−H−AC−H2O]−; 945.5285 [M−H−AC−Glc]−; 783.4795 [M−H−AC−2Glc]−; 621.4282 [M−H−AC−3Glc]−; 459.3848 [M−H−AC−4Glc]− |
24 |
33 | Chikusetsusaponi n IVa |
29.2 61 |
C42H66 O14 |
794.44 53 |
793.44 06 |
3.9 | 631.3770 [M−H−Glc]−; 613.7845 [M−H−Glc−H2O]−; 569.3789 [M−H−2Glc−CO2−H2O]−; 455.3485 [M−H−2Glc−Acid]− |
21, 29 |
34 | Ginsenoside Rd | 29.5 32 |
C48H82 O18 |
946.55 01 |
945.54 57 |
3.0 | 783.4816 [M−H−Glc]−; 621.4299 [M−H−2Glc]−; 459.3781 [M−H−3Glc]− |
23, 28 |
35 | Ginsenoside Rs1 | 29.8 93 |
C55H92 O23 |
1120.6 029 |
1119.5 993 |
3.3 | 1077.5668 [M−H−Ac]−; 945.5472 [M−H−Ac−Arap]−; 783.4679 [M−H−Ac−Arap−Glc]−; 621.4302 [M−H−Ac−Arap−2Glc]−; 459.3709 [M−H−Ac−Arap−3Glc]− |
28 |
36 | Malonyl-Rd | 30.2 5 |
C51H84 O21 |
1032.5 505 |
1031.5 408 |
−1.8 | 987.5372 [M−H−CO2]−; 945.5301 [M−H−mal]−; 783.4829 [M−H−mal−Glc]−; 621.4292 [M−H−mal−2Glc]−; 459.3823 [M−H−mal−3Glc]− |
23, 28 |
37 | Ginsenoside Rs2 | 30.6 49 |
C55H92 O23 |
1120.6 029 |
1119.6 003 |
4.6 | 1077.5742 [M−H−Ac]−; 945.5422 [M−H−Ac−Araf]−; 915.5121 [M−H−Ac−Glc]−; 783.4852 [M−H−Ac−Araf−Glc]−; 621.4312 [M−H−Ac−Araf−2Glc]−; 459.3818 [M−H−Ac−Araf−3Glc]− |
28 |
38 | Gypenoside XVII | 31.0 41 |
C48H82 O18 |
946.55 01 |
945.54 24 |
−0.4 | 783.4831 [M−H−Glc]−; 621.4288 [M−H−2Glc]−; 459.3804 [M−H−3Glc]− |
26 |
39 | ginsenoside Ra6 | 31.1 36 |
C58H96 O24 |
1176.6 075 |
1175.6 025 |
2.0 | 1107.5847 [M−H−Bu]−; 945.5311 [M−H-Bu−Glc]−; 783.4826 [M−H-Bu−2Glc]−; 621.4338 [M−H-Bu−3Glc]−; 459.3887 [M−H-Bu−4Glc]− |
22 |
40 | ginsenoside Ra7 | 31.7 48 |
C57H94 O23 |
1146.6 186 |
1145.6 150 |
3.7 | 1077.5731 [M−H−Bu]−; 945.5274 [M−H−Bu−Araf]−; 783.4809 [M−H−Bu−Araf−Glc]−; 621.4315 [M−H−Bu−Araf−2Glc]−; 459.3795 [M−H−Bu−Araf−3Glc]− |
22 |
41 | Compound Mc-1 | 31.8 68 |
C47H80 O17 |
916.53 90 |
915.52 99 |
−2.0 | 783.4833 [M−H−Araf]−; 621.4284 [M−H−Araf−Glc]−; 459.3816 [M−H−Araf−2Glc]− |
26 |
42 | Compound O | 32.0 33 |
C47H80 O17 |
916.53 90 |
915.53 00 |
−1.9 | 783.4795 [M−H−Arap]−; 621.4306 [M−H−Arap−Glc]−; 459.3778 [M−H−Arap−2Glc]− |
26 |
43 | Pseudoginsenosid e Rc1 |
32.1 24 |
C50H84 O19 |
988.56 07 |
987.55 61 |
3.2 | 945.5316 [M−H−AC]−; 783.4837 [M−H−AC−Glc]−; 621.4302 [M−H−AC−2Glc]−; 459.3802 [M−H−AC−3Glc]− |
26 |
44 | ginsenoside Ra8/Ra9 |
32.3 05 |
C57H94 O23 |
1146.6 18 |
1145.6 155 |
4.2 | 1077.5731 [M−H−Bu]−; 945.5274 [M−H−Bu−Araf]−; 783.4809 [M−H−Bu−Araf−Glc]−; 621.4315 [M−H−Bu−Araf−2Glc]−; 459.3795 [M−H−Bu−Araf−3Glc]− |
22 |
45 | Gypenoside IX | 32.4 46 |
C47H80 O17 |
916.53 90 |
915.53 52 |
3.8 | 961.5394 [M+HCOO]−; 783.4812 [M−H−Xyl]−; 621.4284 [M−H−Xy−Glc]−; 459.3864 [M−H−Xy−2Glc]− |
26 |
46 | Bu-Gypenoside XVII |
33.7 09 |
C52H86 O19 |
1014.5 757 |
1013.5 650 |
−3.4 | 945.5287 [M−H−Bu]−; 783.4796 [M−H-Bu−Glc]−; 621.4307 [M−H-Bu−2Glc]−; 459.3760 [M−H-Bu−3Glc]− |
22 |
47 | 20(S)-Ginsenosid e Rg3/isomer |
34.0 69 |
C42H72 O13 |
784.49 73 |
783.48 86 |
−1.8 | 621.4291 [M−H−Glc]−; 459.3784 [M−H−2Glc]− |
23, 28 |
48 | Zingibroside R1 | 34.6 13 |
C42H66 O14 |
794.44 53 |
793.44 10 |
4.4 | 631.3742 [M−H−Glc]−; 613.3672 [M−H−Glc−H2O]−; 569.3779 [M−H−2Glc−CO2−H2O]−; 455.3474 [M−H−2Glc−Acid]− |
26, 29 |
49 | Bu-Rd | 34.7 09 |
C52H86 O19 |
1014.5 763 |
1013.5 672 |
−1.3 | 945.5314 [M−H−Bu]−; 783.4778 [M−H-Bu−Glc]−; 621.4255 [M−H-Bu−2Glc]−; 459.3775[M−H-Bu−3Glc]− |
22 |
50 | 20(R)-Ginsenosid e Rg3/isomer |
35.5 36 |
C42H72 O13 |
784.49 73 |
783.49 27 |
3.4 | 621.4245 [M−H−Glc]−; 459.3759 [M−H−2Glc]− |
23, 28 |
51 | 24(R)-pseudogins enoside RT5 |
38.6 59 |
C33H58 O14 |
678.38 27 |
677.37 60 |
1.6 | 677.3823 [M−H]−; | 24 |
52 | Ginsenoside Rk1 | 39.3 51 |
C42H70 O12 |
766.48 67 |
765.47 69 |
−2.6 | 03.4125 [M−H−Glc]− |
23, 28 |
53 | Ginsenoside Rg5 | 39.7 82 |
C42H70 O12 |
766.48 67 |
765.47 59 |
−3.9 | 603.4125 [M−H−Glc]− |
23, 28 |
54 | Ginsenoside Rh2 | 40.1 17 |
C36H62 O8 |
622.44 45 |
621.43 86 |
3.1 | 459.3792 [M−H−Glc]− |
23, 28 |
[M−H]−;
Glc=β-D-glucopyranosyl (162 Da); Rha=α-L-rhamnopyranosyl (146 Da);
Ara=β-D-arabopyranosyl (132 Da); Xyl=β-D-Xylopyranosyl (132 Da);
Glc-Acid=β-D-glucopyranosylacetyl acid (176 Da); Ac=acetyl (42 Da); Bu=trans-but-2-enoyl (68 Da); Mal=malonyl (86 Da).